Finally, we found that after inhibiting SDC1 and ITGA2 expression in BxPC-3 and MIA-PaCa2 cell lines, the tumor size was significantly reduced, showing a potential therapeutic effect (Fig. 8H, Table S5,S5). This evidence concerns the gene SDC1 and neoplasm.